$8.510
+0.174 (+2.04%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de XGN por análisis de gráficos similares
Alphio's XGN stock price prediction model matches the current Exagen Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.74 (+3.48%). The 1-week path is $8.11 (+8.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Exagen Inc?
Exagen Inc is a good buy right now due to its current price of $8.39, which is significantly below the analyst price target of $12, indicating a potential upside of 43%. Additionally, the company reported a 16% year-over-year revenue growth in Q2 2026, reaching $19.9 million, and has raised its full-year revenue guidance to between $72 million and $75 million. However, the main risk is the negative net income, which was -$3.2 million in Q2 2026, indicating ongoing financial challenges that investors should consider.
XGN cerró en $8.51 el Wednesday, tras subir +2.04%
Exagen Inc (XGN) last closed at $7.48, losing -12.10%. These facts feed the 1-day and 1-week XGN price prediction above.
Factores de la previsión
Los factores de la previsión de Exagen Inc (XGN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de XGN, ordenadas por similitud.
Análisis de estacionalidad de XGN
Historically the probability of a positive November return for XGN is 100.00%. September offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de XGN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $4.48 | $5.87 | $6.38 | -21.54% |
| Dec 2026 | $4.82 | $6.60 | $7.16 | -11.77% |
En 2026, se proyecta que Exagen Inc (XGN) oscile entre $4.48 y $7.16.
Previsión mensual de Exagen Inc para 2026
En Nov de 2026, se proyecta que Exagen Inc promedie $5.87, con un mínimo de $4.48 y un máximo de $6.38.
En Dec de 2026, se proyecta que Exagen Inc promedie $6.60, con un mínimo de $4.82 y un máximo de $7.16.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.